Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03345134
Title Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shaheen Alanee
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.